Well-differentiated thymic carcinoma: a clinico-pathological study

1992 ◽  
Vol 420 (2) ◽  
pp. 179-183 ◽  
Author(s):  
Edoardo Pescarmona ◽  
Stefano Rosati ◽  
Erino A. Rendina ◽  
Federico Venuta ◽  
Carlo D. Baroni
Keyword(s):  
Thymic Carcinoma ◽  
Pathological Study ◽  
Well Differentiated

scholarly journals Well-differentiated thymic carcinoma: Is it thymic carcinoma or not?

1999 ◽  
Vol 117 (3) ◽  
pp. 628-630 ◽  
Author(s):  
Akira Masaoka ◽  
Yosuke Yamakawa ◽  
Yoshitaka Fujii
Keyword(s):  
Thymic Carcinoma ◽  
Well Differentiated

Ectopic cervical well differentiated thymic carcinoma: report of a diagnostically challenging rare case

Pathology ◽  
2019 ◽  
Vol 51 (1) ◽  
pp. 122-125
Author(s):  
Giap Hean Goh ◽  
Fei Fan Wang ◽  
Kwok Seng Loh ◽  
Fredrik Petersson
Keyword(s):  
Rare Case ◽  
Thymic Carcinoma ◽  
Well Differentiated

Well-Differentiated Thymic Carcinoma

1992 ◽  
Vol 16 (12) ◽  
pp. 1153-1169 ◽  
Author(s):  
Thomas Kirchner ◽  
Berthold Schalke ◽  
Jürgen Buchwald ◽  
Mary Ritter ◽  
Alexander Marx ◽  
...  
Keyword(s):  
Thymic Carcinoma ◽  
Well Differentiated

scholarly journals Well Differentiated B3 Thymoma complicated with Vena Cava Superior Syndrome undergo Debulking and Chemotherapy

2020 ◽  
Vol 2 (1) ◽  
pp. 56-61
Author(s):  
Wayan Putra ◽  
◽  
Iin Chozin ◽  
Kenthy Wantry ◽  
Artono Isharanto ◽  
...  
Keyword(s):  
Genetic Factors ◽  
Thymic Carcinoma ◽  
Objective Response ◽  
Vena Cava ◽  
Stage Iv ◽  
Stadium Iv ◽  
Vena Cava Superior ◽  
Vena Cava Superior Syndrome ◽  
Well Differentiated ◽  
The Right

Background: Thymoma is a rare neoplasm. This incident is comparable to 390 new cases reported per year. Genetic factors are believed to be one of the factors of B3 thymoma and thymus carcinoma. Multimodality of thymoma therapy (surgery, radiation and chemotherapy) gives better results. Case Report: Mr A, 29 years old, with initial diagnosis of stage IV thymoma (according to Masaoka) with SVKS then undergo debulking, followed by chemotherapy with a regimen of Cisplatin + Vincristin, Cyclophospamid, Doxorubicin, Prednison every 21 days as much as 6 times. Subjective responses indicated by reduced complaints of chest pain and loss of swelling of the right arm. Semisubjective response indicated by increase of body weight. Objective response is progressive, so can be continued with second line chemotherapy or radiotherapy. Conclusion: The prognosis of patient with well differentiated thymic carcinoma stadium iv (thymoma b3) complicated with vena cava superior syndrome was poor because of the objective response of the chemotherapy was progressive, and the relapse case was higher.

Well-differentiated thymic carcinoma: A newly defined tumor type showing high association with myasthenia gravis

1989 ◽  
Vol 2 (6) ◽  
pp. 911
Author(s):  
Th. Kirchner ◽  
B. Schalke ◽  
B. Arnold ◽  
A. Marx ◽  
H.K. Müller-Hermelink
Keyword(s):  
Myasthenia Gravis ◽  
Thymic Carcinoma ◽  
Tumor Type ◽  
High Association ◽  
Well Differentiated

Erlotinib in Advanced Well-Differentiated Thymic Carcinoma with Overexpression of EGFR: A Case Report

2008 ◽  
Vol 94 (6) ◽  
pp. 849-852 ◽  
Author(s):  
Rebecca Pedersini ◽  
Emanuela Vattemi ◽  
Maria Rita Lusso ◽  
Guido Mazzoleni ◽  
Heinrich Ebner ◽  
...  
Keyword(s):  
Thymic Carcinoma ◽  
Growth Factor Receptor ◽  
Ideal Solution ◽  
Egfr Expression ◽  
Therapeutic Choice ◽  
Heavily Pretreated ◽  
Epidermal Growth ◽  
Well Differentiated ◽  
Erlotinib Therapy ◽  
The Ideal

Aims and Background Advanced chemorefractory epithelial thymic tumors are still a challenge in clinical oncology. A therapeutic approach targeting a key molecular pathway could be the ideal solution in a neoplasm that can overexpress epidermal growth factor receptor (EGFR) in the epithelial component. Methods A patient with metastatic heavily pretreated thymic carcinoma was evaluated for EGFR expression in the primary tumor. Results Strong EGFR expression was revealed by immunohistochemistry. The patient received erlotinib therapy but had obtained no response after four months of treatment. Conclusion This preliminary experience suggests that erlotinib may not be a useful therapeutic choice in advanced pretreated thymic carcinomas.

A Case of Well-Differentiated Thymic Carcinoma with Extensive Cystic Degeneration

1999 ◽  
Vol 46 (5) ◽  
pp. 718 ◽  
Author(s):  
Kyung Wook Kim ◽  
Byeong Kee Choi ◽  
Byung Chun Chung ◽  
Yoon Soo Chang ◽  
Hyung Jung Kim ◽  
...  
Keyword(s):  
Thymic Carcinoma ◽  
Cystic Degeneration ◽  
Well Differentiated

Ultrastructure of NPC/HK1 cells heterotransplanted in athymic nude mice

1982 ◽  
Vol 40 ◽  
pp. 236-237
Author(s):  
E.C. Chew ◽  
C.L. Li ◽  
D.P. Huang ◽  
H.C. Ho ◽  
L.S. Mak ◽  
...  
Keyword(s):  
Cell Line ◽  
Nude Mice ◽  
Biopsy Specimen ◽  
Epithelial Cell Line ◽  
Present Communication ◽  
Recurrent Tumour ◽  
Athymic Nude Mice ◽  
Cell Line Establishment ◽  
Fine Structures ◽  
Well Differentiated

An epithelial cell line, NPC/HK1, has recently been established from a biopsy specimen of a recurrent tumour of the nasopharynx which was histologically diagnosed as a moderately to well differentiated squamous cell carcinoma. A definite decrease in the amount of tonofilaments and desmosomes in the NPC/HK1 cells during the cell line establishment was observed. The present communication reports on the fine structures of the NPC/HK1 cells heterotraneplanted in athymic nude mice.

An Established Epithelial Cell Line (NPC/HK1) from a Nasopharyngeal Carcinoma - II. A Sem Study

1982 ◽  
Vol 40 ◽  
pp. 224-225
Author(s):  
Li C.L. ◽  
Chew E.C. ◽  
Huang D.P. ◽  
Ho H.C. ◽  
Mak L.S. ◽  
...  
Keyword(s):  
Nasopharyngeal Carcinoma ◽  
Epithelial Cell ◽  
Surface Morphology ◽  
Cell Line ◽  
Epithelial Cell Line ◽  
Present Communication ◽  
Cells In Culture ◽  
Sem Study ◽  
Well Differentiated

An epithelial cell line, NPC/HK1, has recently been successfully established from a nasopharyngeal carcinoma of the moderately to well differentiated squamous type. The present communication reports on the surface morphology of the NPC/HK1 cells in culture.

Sign in / Sign up

Export Citation Format

Share Document